|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 213/82 | (2006.01) |
| C07D 241/24 | (2006.01) | ||
| C07D 233/20 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 405/12 | (2006.01) | ||
| C07C 43/20 | (2006.01) | ||
| A61K 31/4412 | (2006.01) | ||
| A61K 31/4427 | (2006.01) | ||
| A61P 3/04 | (2006.01) |
| (11) | Number of the document | 2208727 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08153866.2 |
| Date of filing the European patent application | 2003-09-17 | |
| (97) | Date of publication of the European application | 2010-07-21 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-29 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (30) | Number | Date | Country code |
| 412158 P | 2002-09-19 | US |
| (72) |
Blanco-Pillado, Maria-Jesus, US
Chappell, Mark Donald, US
De La Torre, Marta Garcia, ES
Diaz Buezo, Nuria, ES
Fritz, James Erwin, US
Holloway, William Glen, US
Matt, James Edward Junior, US
Mitch, Charles Howard, US
Pedregal-Tercero, Concepcion, ES
Quimby, Steven James, US
Siegel, Miles Goodman, US
Smith, Dana Rae, US
Stucky, Russell Dean, US
Takeuchi, Kumiko, US
Thomas, Elizabeth Marie, US
Wolfe, Chad Nolan, US
|
| (73) |
Eli Lilly & Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Diarilo eteriai kaip opioido receptoriaus antagonistai |
| Diaryl ethers as opioid receptor antagonist |
| Payment date | Validity (years) | Amount | |
| 2022-08-18 | 347.00 EUR |